Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma

BACKGROUND: We conducted a pilot phase II study to evaluate the efficacy and safety of S-1 as a first-line, S-1 plus cisplatin as a second-line, and weekly paclitaxel as a third-line therapy for advanced gastric cancer. PATIENTS AND METHODS: Between 2002 and 2005, 19 patients were enrolled in this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rino, Yasushi, Yukawa, Norio, Wada, Nobuyuki, Suzuki, Makoto, Murakami, Hitoshi, Yamada, Takanobu, Nakayama, Hirotaka, Yamamoto, Naoto, Sato, Tsutomu, Yamada, Roppei, Ohshima, Takashi, Masuda, Munetaka, Imada, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161668/
https://www.ncbi.nlm.nih.gov/pubmed/21892302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161668/
https://www.ncbi.nlm.nih.gov/pubmed/21892302

Ejemplares similares